Explore our complete collection of peptide guides. Benefits, dosing, mechanisms, and what to expect.
Showing 85 peptides35 available to buy
Ascension product link
A small molecule NNMT inhibitor that promotes fat cell metabolism and may support weight loss without affecting the central nervous system.
Ascension product link
A modified fragment of human growth hormone designed to stimulate fat metabolism without the growth-promoting effects of full HGH.
Ascension product link
An 11-amino acid erythropoietin-derived peptide that activates the innate repair receptor for tissue protection without hematopoietic effects.
Ascension product link
A gastric pentadecapeptide with remarkable tissue-protective and regenerative properties across multiple organ systems.
Ascension product link
A long-acting amylin analog that suppresses appetite and enhances satiety—being developed by Novo Nordisk as a complement to GLP-1 drugs for superior weight loss.
Ascension product link
A synthetic GHRH analog with enhanced stability and prolonged GH-releasing activity, available in both standard and DAC-conjugated forms.
Ascension product link
A naturally occurring neuropeptide that promotes deep delta-wave sleep, stress resilience, and may help normalize disrupted sleep patterns.
Ascension product link
A tetrapeptide that activates telomerase, the enzyme responsible for maintaining telomere length, potentially addressing one of the fundamental mechanisms of cellular aging.
Ascension product link
A D-retro-inverso senolytic peptide studied for disrupting the FOXO4-p53 interaction in senescent-cell research.
Ascension product link
A naturally occurring copper peptide with powerful skin regeneration, wound healing, and anti-aging properties backed by decades of research.
Ascension product link
How human chorionic gonadotropin acts on the LH receptor, why it lasts days instead of minutes, and what that means for timing.
Ascension product link
A highly selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol, prolactin, or appetite hormones.
Ascension product link
A neuropeptide that serves as the master regulator of the reproductive axis, controlling GnRH release and fertility in both sexes.
Ascension product link
A master regulator of the reproductive hormone system that triggers natural LH and testosterone release, with potential applications in fertility, hormone optimization, and PCT.
Ascension product link
A potent anti-inflammatory tripeptide derived from alpha-MSH with remarkable effects on inflammatory bowel conditions and immune modulation.
Ascension product link
A human host defense peptide with broad-spectrum antimicrobial activity and powerful immunomodulatory properties for wound healing and infection control.
Ascension product link
A synthetic melanocortin peptide that stimulates melanin production, developed for photoprotection and approved for treating erythropoietic protoporphyria (EPP).
Ascension product link
A synthetic peptide that stimulates melanin production for skin tanning while also producing notable effects on libido and appetite suppression.
Ascension product link
A synthetic melanocortin peptide analog that stimulates melanin production for skin pigmentation and activates sexual arousal pathways.
Ascension product link
A mitochondria-derived peptide with profound effects on metabolism, exercise capacity, and aging—a rising star in longevity research.
Ascension product link
A cellular redox coenzyme and substrate for sirtuins, PARPs, and CD38 in longevity and metabolism research.
Ascension product link
A nine-amino acid neuropeptide hormone involved in social bonding, trust, anxiety reduction, and reproductive functions.
Ascension product link
A synthetic bioregulatory tripeptide that targets pineal gland and central nervous system function, with neuroprotective and geroprotective properties.
Ascension product link
An FDA-approved melanocortin receptor agonist that acts centrally in the brain to promote sexual arousal and desire.
Ascension product link
A groundbreaking triple receptor agonist achieving unprecedented 24.2% weight loss in clinical trials, representing the next evolution in obesity pharmacotherapy.
Ascension product link
A synthetic anxiolytic peptide derived from tuftsin, developed in Russia for anxiety reduction, cognitive enhancement, and immunomodulation.
Ascension product link
A GLP-1 receptor agonist that mimics natural gut hormones to reduce appetite, slow digestion, and support significant weight loss results.
Ascension product link
A synthetic heptapeptide nootropic derived from ACTH with neuroprotective, cognitive-enhancing, and neurorestorative properties.
Ascension product link
A synthetic 29-amino acid peptide analog of growth hormone-releasing hormone (GHRH) that stimulates natural GH production from the pituitary gland.
Ascension product link
A mitochondria-targeting peptide that protects cells from oxidative damage and restores energy production—in clinical trials for heart failure and mitochondrial diseases.
Ascension product link
A synthetic peptide fragment promoting tissue repair, reduced inflammation, and accelerated recovery from muscle, tendon, and ligament injuries.
Ascension product link
An FDA-approved growth hormone-releasing hormone analog that reduces visceral fat accumulation and stimulates natural GH production.
Ascension product link
Thymosin Alpha 1 is a synthetic 28–amino acid peptide studied for its immunomodulatory effects, supporting host defense, tissue recovery, and immune balance in diverse experimental models.
Ascension product link
A dual-action incretin that has achieved unprecedented weight loss results in clinical trials, now FDA-approved as Mounjaro and Zepbound.
Ascension product link
A 28-amino acid neuropeptide with potent anti-inflammatory, immunomodulatory, and neuroprotective properties being researched for autoimmune conditions and gut disorders.
An FDA-approved synthetic analog of parathyroid hormone-related protein (PTHrP) that promotes bone formation and reduces fracture risk in postmenopausal osteoporosis.
A chimeric proapoptotic peptide that selectively targets the vasculature of white adipose tissue, inducing fat cell death through blood supply disruption.
A topical cosmetic peptide marketed as 'Botox in a jar' that reduces wrinkle appearance by inhibiting muscle contraction at the neuromuscular junction.
Cerebrolysin is a neuropeptide mixture derived from porcine brain proteins that mimics BDNF, GDNF, and NGF. Used clinically in 50+ countries for stroke, TBI, Alzheimer's, and dementia. Complete guide to benefits, dosage protocols, side effects, and clinical evidence.
A neuropeptide with potent anti-inflammatory and immunomodulatory properties, closely related to somatostatin but with distinct receptors and therapeutic potential.
An extremely potent cognitive-enhancing compound derived from angiotensin IV, studied for memory enhancement and potential neurodegenerative disease applications.
An FDA-approved GLP-1 receptor agonist for type 2 diabetes and cardiovascular risk reduction, administered once weekly.
The first GLP-1 receptor agonist approved for diabetes, derived from Gila monster venom, available in twice-daily and once-weekly formulations.
A myostatin inhibitor and activin-binding protein that promotes muscle growth by blocking the body's natural limiters on muscle development.
The primary hunger hormone that stimulates appetite, GH release, and gastric motility—the natural ligand for the GHS receptor targeted by GHRPs.
A potent growth hormone secretagogue that balances strong GH release with more moderate appetite stimulation than GHRP-6, making it a middle-ground option.
A potent growth hormone secretagogue known for robust GH release and significant appetite stimulation—the original GH-releasing peptide that started the secretagogue era.
The body's master antioxidant — a tripeptide critical for detoxification, oxidative stress defense, immune function, and cellular health.
The natural gonadotropin-releasing hormone used to stimulate LH and FSH production, commonly used in fertility treatment and post-cycle therapy research.
A potent synthetic growth hormone releasing hexapeptide with unique cardioprotective properties and the strongest GH release among GHRP family peptides.
The C-terminal fragment of human growth hormone responsible for fat metabolism, studied for its lipolytic activity without the growth-promoting effects of full-length HGH.
A mitochondrial-derived peptide with cytoprotective and neuroprotective properties, showing promise in aging, Alzheimer's research, and metabolic health.
A truncated, highly potent variant of IGF-1 that bypasses binding proteins for enhanced bioavailability and tissue-specific anabolic effects.
What the Long R3 modifications change: binding-protein escape, a 20–30 hour half-life, and the timing that follows from it.
A naturally-occurring dipeptide with potent anti-glycation, antioxidant, and anti-aging properties found in high concentrations in muscle and brain tissue.
A long-acting somatostatin analog for acromegaly and neuroendocrine tumors—with the convenience of self-injectable depot formulation.
An FDA-approved 14-amino acid peptide that activates guanylate cyclase-C receptors to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation.
An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, with extensive clinical trial evidence supporting its metabolic benefits.
An FDA-approved GLP-1 receptor agonist used for type 2 diabetes with unique pharmacokinetics favoring postprandial glucose control.
A collagen-boosting signal peptide widely used in anti-aging skincare to reduce wrinkles and improve skin firmness.
The short-lived native form of mechano growth factor: minutes of activity, local muscle signalling, and how it differs from PEG-MGF.
An orally-active growth hormone secretagogue that mimics ghrelin signaling to increase GH and IGF-1 levels without injections.
A modified growth hormone-releasing hormone analog with enhanced stability, commonly paired with GHRPs for synergistic GH release.
An enhanced variant of Selank with improved stability and bioavailability, offering anxiolytic and cognitive effects through GABA modulation.
An enhanced variant of Semax with improved stability and potency, offering cognitive enhancement and neuroprotective effects.
An 82-amino acid peptide derived from nucleobindin-2 that regulates appetite, metabolism, and energy homeostasis through hypothalamic signaling.
A 36-amino acid neuropeptide that serves as one of the most abundant signaling molecules in the brain, regulating appetite, stress response, anxiety, and circadian rhythms.
A synthetic somatostatin analog used to treat acromegaly, carcinoid tumors, and severe diarrhea—one of the most clinically important peptide drugs in endocrinology.
A neuropeptide critical for wakefulness, appetite regulation, and energy homeostasis with therapeutic implications for narcolepsy and metabolic disorders.
A synthetic 21-amino acid peptide derived from Ciliary Neurotrophic Factor (CNTF) that promotes neurogenesis and cognitive enhancement.
A 38-amino acid neuropeptide with potent neuroprotective, anti-inflammatory, and regenerative properties across multiple organ systems.
A pegylated variant of IGF-1 splice variant with extended half-life, studied for localized muscle repair and hypertrophy signaling.
A GLP-1/glucagon dual agonist designed for better body composition—promoting fat loss while preserving muscle mass during weight loss.
A gut-derived satiety hormone that reduces appetite and regulates energy balance, with significant research implications for obesity treatment.
An FDA-approved synthetic amylin analog that complements insulin therapy by slowing gastric emptying, reducing glucagon secretion, and enhancing satiety in diabetes management.
A cell-penetrating peptide targeting the Wnt/β-catenin pathway to activate hair follicle stem cells and promote hair regrowth.
An FDA-approved MC4R agonist peptide for treating obesity caused by rare genetic disorders affecting the leptin-melanocortin pathway.
An 8-amino acid peptide that mimics the N-terminus of SNAP-25 to reduce muscle contractions and soften expression lines without injections.
A dual GLP-1 and glucagon receptor agonist showing significant weight loss and liver fat reduction in clinical trials, positioned as a next-generation obesity and MASH therapeutic.
An FDA-approved parathyroid hormone analog used to treat osteoporosis by stimulating new bone formation rather than just preventing bone loss.
A thymic polypeptide bioregulator with immunomodulatory and geroprotective properties, developed from decades of Russian peptide bioregulation research.
A synthetic pentapeptide derived from thymopoietin that modulates T-cell function and enhances immune system regulation.
A 43-amino acid protein that orchestrates tissue repair, cell migration, and wound healing—the full molecule behind TB-500's regenerative reputation.
A zinc-dependent thymic nonapeptide essential for T-cell maturation, immune regulation, and emerging anti-aging research.
An FDA-approved modified C-type natriuretic peptide (CNP) analog that promotes bone growth by counteracting FGFR3 signaling in children with achondroplasia.
Peptides are short chains of amino acids that play important roles in the body. They're used for everything from muscle recovery and fat loss to anti-aging, cognitive enhancement, and immune support.
Our database covers the most popular peptides, including healing peptides like TB-500 and BPC-157, growth hormone boosters like CJC-1295 and Ipamorelin, weight loss peptides like Semaglutide and Retatrutide, and many more. Each guide includes dosing info, benefits, side effects, and how they work.
In-depth research articles on specific peptides, protocols, and findings.
What retatrutide discontinuation can mean for appetite, weight regain, tapering, side effects, and maintenance after stopping retatrutide.
Oct 18, 2026Retatrutide cagrilintide stack (RetaCagri) explained: the triple agonist plus amylin rationale, reported research dosing, expected weight loss benefits and side effects.
Oct 18, 2026Complete guide to microdosing retatrutide — split dosing schedules, peak-to-trough ratios, dosage calculations, and who should consider it. Based on PK modeling and community experience.
Oct 18, 2026Zolucatetide (FOG-001) is the first drug to block β-catenin directly. Every human result in desmoid tumors and FAP, side effects by dose, the trial, and when it could be approved.
Oct 18, 2026RYZ101 (actinium-225 DOTATATE) is the radioactive peptide that met its Phase 3 goal in October 2026. How it kills cancer cells, every study, side effects and trials.
Oct 18, 2026AMCP is a ring-shaped antimicrobial peptide published October 11, 2026. In the lab it killed the acne bacterium at 0.5 µg/mL, cut oil-gland fat 40% and inflammation signals up to 96%. No published human data yet. Who makes it, the label name, and what works for acne today.
Oct 18, 2026Does retatrutide cause hair loss? No trial has published a rate yet. Here are the Zepbound and Wegovy label numbers, who sheds, when it starts and what helps.
Oct 18, 2026Retatrutide for women: phase 2 data shows women lost up to 28.5% vs 19.8% for men. Side effects, birth control, pregnancy, PCOS, menopause and dosing.
Oct 18, 2026Not losing weight on retatrutide? Check your progress against trial benchmarks, then work through 9 causes, from weak vials to units math, plus a fix plan.
Oct 18, 2026Eloralintide vs retatrutide: Lilly's amylin shot hit 20.1% at 48 weeks, reta 24.2% (28.3% at 80). Side effects, lean mass, EloraTZP and approval dates.
Oct 18, 2026Tesamorelin vs retatrutide: one cuts visceral fat without weight loss, the other cuts 24% of body weight. Trials, side effects, cost and the tesa-reta stack.
Oct 18, 2026Retatrutide and alcohol: no trial has tested the pair. What the semaglutide trials show, the 4 real risks, and how to drink more safely on reta.
Oct 18, 2026Does retatrutide make you tired? Trial fatigue was 9.7% at 12 mg vs 4.3% placebo. See the 6 real causes, a timeline, fixes, and red flags that need a doctor.
Oct 18, 2026Is retatrutide safe? What six trials show on side-effect dropouts, deaths and cancer risk, what is still unknown, and the bigger risk of unregulated vials.
Oct 18, 2026How to inject retatrutide: where to inject (abdomen, thigh, arm), units on a U-100 syringe, best time, missed doses and site reactions, from the FDA labels.
Oct 18, 2026NAD+ nasal spray delivers about 5 mg per spray, a fraction of an IV drip. The per-spray math, what your nose actually absorbs, how it compares to injections and IV, and the label checks to run before you buy.
Oct 10, 2026BioIGF-LR examined: the undisclosed structure, the missing certificate, the 17-day stability claim, the one affiliate protocol behind the 2 mg dose, and how it compares with the two long-acting IGF-1s that came before it.
Oct 10, 2026A buyer-focused IGF-1 LR3 guide covering for sale listings, COA verification, vendor quality, cold-chain handling, pricing, and red flags.
Oct 10, 2026How much IGF-1 LR3 to take, how long to cycle it, when to inject, and what side effects to watch for — complete protocol guide with dosage chart.
Oct 10, 2026IGF-1 LR3 is a long-acting analog of IGF-1 with a 20-30 hour half-life. Here's what it actually does, real before and after results, and how it compares to regular IGF-1.
Oct 10, 2026Peptides for osteoporosis, graded by human evidence: teriparatide and abaloparatide cut spine fractures 65% and 86%, collagen peptides moved a T-score by 0.1, and BPC-157, TB-500, GHK-Cu and sermorelin have no human bone data.
Oct 9, 2026EB613 is Entera Bio's once-daily teriparatide tablet. Phase 2 raised spine density 2.7% over placebo in 161 women; the FDA accepted a 750-woman Phase 3 in June 2026. Status, cost context and a nine-vendor check.
Oct 9, 2026Oral and needle-free peptides explained: which peptides survive the gut, why most do not, sublingual vs capsule vs liquid drops, and how to buy oral research peptides safely.
Oct 9, 2026Peptides for arthritis, graded by evidence: ACTH gel is approved for RA, semaglutide cut knee OA pain in 407 people, and BPC-157 rests on a 16-person survey.
Oct 9, 2026